```html

Duey’s Syndrome (HELLP)

Overview

Duey’s syndrome, more commonly known by the acronym **HELLP**, is a severe, life‑threatening complication of pregnancy that falls under the broader umbrella of preeclampsia. The name HELLP stands for:

• H – Hemolysis (destruction of red blood cells)
• E – Elevated Liver enzymes (indicating liver injury)
• L – Low Platelet count (thrombocytopenia)

It typically develops in the **third trimester** but can appear earlier or even postpartum. While HELLP is rare, it carries a high risk of maternal and fetal morbidity if not recognized promptly.

Who It Affects

• Pregnant women, most often between **28–37 weeks** gestation.
• More common in **first‑time mothers** (nulliparous women).
• Occurs about **0.5–0.9%** of all pregnancies and **10–20%** of women with severe preeclampsia.<sup>[1] Mayo Clinic</sup>

Prevalence by Region

Incidence rates are similar worldwide, though data from high‑resource countries report slightly higher detection (≈0.8%) because of better prenatal screening. In low‑resource settings the condition may be under‑diagnosed, leading to higher maternal mortality (up to 5‑10%).<sup>[2] WHO</sup>

Symptoms

Symptoms can develop rapidly and vary from mild to severe. Not all women experience the classic triad of symptoms; some present only with laboratory abnormalities.

General Symptoms

• Headache – often severe, unresponsive to usual analgesics.
• Upper abdominal or right‑upper‑quadrant pain – feels like a dull ache or sharp stabbing pain.
• Nausea and vomiting – may be mistaken for typical pregnancy‑related morning sickness.
• Fatigue or malaise – excessive tiredness beyond normal pregnancy fatigue.
• Visual disturbances – blurred vision, flashing lights, or temporary loss of vision.

Specific Signs of the HELLP Triad

• Hemolysis – dark‑colored urine, jaundice, or a “sickly” feeling caused by breakdown of red blood cells.
• Elevated Liver Enzymes – right‑side upper abdominal pain, tenderness, and sometimes a feeling of fullness.
• Low Platelet Count – easy bruising, petechiae (tiny red spots), or nosebleeds.

Red‑Flag Symptoms Requiring Immediate Attention

• Sudden, severe abdominal pain, especially if it radiates to the back.
• Rapid swelling of the face, hands, or feet (edema) with shortness of breath.
• Severe headache that does not improve with rest or medication.
• Bleeding from gums, bleeding gums after brushing, or prolonged vaginal bleeding.
• Decreased fetal movement.

Causes and Risk Factors

The exact cause of HELLP is still not fully understood, but it is believed to involve abnormal placental development leading to endothelial damage, inflammation, and a cascade of clotting abnormalities.

Known Risk Factors

• Previous preeclampsia or HELLP – a history raises recurrence risk to 20‑30%.
• Multiparity – although many cases occur in first‑time mothers, women with multiple pregnancies are at higher risk.
• Maternal age – women <35 or >40 years have a slightly increased risk.
• Obesity – BMI ≥30 kg/m² is associated with higher incidence.
• Chronic hypertension, renal disease, or autoimmune disorders (e.g., systemic lupus erythematosus).
• Family history of preeclampsia or HELLP.
• In vitro fertilization (IVF) or other assisted reproductive technologies – the hormonal milieu may predispose to vascular changes.

Pathophysiology (Simplified)

1. Abnormal placental implantation → poor blood flow.
2. Release of anti‑angiogenic factors → endothelial dysfunction.
3. Systemic inflammatory response → activation of the clotting cascade.
4. Red blood cell destruction (hemolysis), liver cell injury, and platelet consumption (thrombocytopenia).

Diagnosis

Because symptoms can be nonspecific, the diagnosis relies heavily on laboratory testing coupled with clinical assessment.

Key Laboratory Tests

• Complete Blood Count (CBC) – platelets <150,000/µL or lower confirm the “L”.
• Lactate Dehydrogenase (LDH) – >600 IU/L indicates hemolysis.
• Peripheral Smear – schistocytes (fragmented RBCs) support hemolysis.
• Serum Bilirubin – indirect bilirubin >1.2 mg/dL suggests hemolysis.
• Aspartate Aminotransferase (AST) & Alanine Aminotransferase (ALT) – values >70 U/L signify liver involvement.
• Urinalysis – proteinuria can be present but is not required for HELLP.

Imaging Studies (When Needed)

• Ultrasound – assesses fetal growth, amniotic fluid volume, and may detect hepatic subcapsular hematoma.
• CT or MRI – reserved for severe abdominal pain to rule out hepatic rupture.

Diagnostic Criteria

Most clinicians use the **Mississippi classification**, which requires:

1. Platelet count <150,000/µL.
2. AST or ALT ≥70 U/L.
3. LDH ≥600 U/L or evidence of hemolysis.

Severity can be categorized as:

• Class I – Platelets <50,000/µL.
• Class II – Platelets 50,000‑100,000/µL.
• Class III – Platelets 100,000‑150,000/µL.

Treatment Options

Management focuses on stabilizing the mother, preventing progression, and delivering the baby at the optimal time.

Immediate Stabilization

• Hospital admission – usually to a high‑risk obstetrics unit.
• Blood pressure control – IV labetalol, hydralazine, or nifedipine to keep BP <160/110 mmHg.
• Seizure prophylaxis – magnesium sulfate 4‑6 g IV loading dose, then 1‑2 g/h infusion.
• IV fluids judiciously – avoid fluid overload, monitor urine output.
• Blood product transfusion – platelet transfusion if <50,000/µL and bleeding, or packed red cells for severe anemia.

Definitive Management – Delivery

Delivery is the only cure. Timing depends on gestational age, maternal status, and fetal condition.

• Before 34 weeks – aim for corticosteroids (betamethasone 12 mg IM q24h × 2) to accelerate fetal lung maturity, then induce labor or perform Cesarean if maternal condition deteriorates.
• 34 weeks or later – delivery is usually recommended as the benefits outweigh risks.

Adjunctive Medications

• Corticosteroids – besides fetal lung maturation, may improve maternal platelet counts.
• Aspirin (low dose 81 mg daily) – for high‑risk women in early pregnancy to prevent preeclampsia, not a treatment once HELLP is established.
• Antihypertensives postpartum – often needed for several weeks.

Post‑delivery Care

• Monitor liver function, CBC, and blood pressure daily for at least 48‑72 hours.
• Continue magnesium sulfate for 24 hours postpartum to prevent seizures.
• Assess for postpartum hemorrhage and manage accordingly.

Living with Duey’s Syndrome (HELLP)

Even after delivery, many women need ongoing care. Below are practical tips for daily life.

Follow‑up Schedule

• First postpartum visit within **1–2 weeks**; check BP, labs, and mental health.
• Subsequent visits every **4‑6 weeks** until blood pressure and labs normalize (often 6‑12 weeks).

Self‑Monitoring

• Home blood pressure monitoring – aim for <140/90 mmHg.
• Track any new headaches, visual changes, or swelling.
• Maintain a log of fetal movements during any subsequent pregnancy.

Lifestyle Adjustments

• Nutrition – balanced diet rich in fruits, vegetables, whole grains, lean protein; limit sodium to ≤2,300 mg/day.
• Physical activity – after clearance, moderate walking or prenatal‑postnatal yoga is beneficial.
• Weight management – aim for a BMI <30 kg/m² before a future pregnancy.
• Stress reduction – mindfulness, breathing exercises, and adequate sleep (7‑9 h/night).

Emotional Health

Experiencing a life‑threatening pregnancy complication can cause anxiety or post‑traumatic stress. Seek counseling, join support groups, or talk with a mental‑health professional if you feel overwhelmed.

Prevention

Because the exact trigger is unknown, prevention focuses on early detection of preeclampsia and modifying risk factors.

Primary Prevention Strategies

• Low‑dose aspirin (81 mg daily) from 12‑16 weeks onward for women with high‑risk factors (e.g., chronic hypertension, prior preeclampsia).<sup>[3] ACOG</sup>
• Calcium supplementation (1,000 mg/day) in populations with low dietary calcium intake.<sup>[4] WHO</sup>
• Maintain a healthy weight before conception.
• Control chronic conditions (diabetes, hypertension) with the help of a primary care provider.
• Regular prenatal visits – early detection of rising blood pressure or proteinuria.

Screening During Pregnancy

• Blood pressure checks at every prenatal visit.
• Urine dipstick for protein at each visit after 20 weeks.
• If risk factors exist, consider serial blood work (CBC, liver enzymes) starting at 28 weeks.

Complications

If HELLP is not promptly treated, both mother and baby face serious risks.

Maternal Complications

• Disseminated Intravascular Coagulation (DIC) – widespread clotting leading to bleeding.
• Placental abruption – premature separation of placenta.
• Hepatic hematoma or rupture – life‑threatening internal bleeding.
• Acute kidney injury.
• Stroke or intracranial hemorrhage.
• Long‑term hypertension and increased cardiovascular disease risk.

Fetal/Neonatal Complications

• Preterm birth and associated respiratory distress.
• Intrauterine growth restriction (IUGR).
• Low birth weight.
• Stillbirth (higher risk if delivery delayed).

When to Seek Emergency Care

---

References

1. Mayo Clinic. “HELLP syndrome.” Updated 2023. https://www.mayoclinic.org
2. World Health Organization. “Maternal mortality and morbidity: pre‑eclampsia and HELLP.” 2022. https://www.who.int
3. American College of Obstetricians and Gynecologists. “Practice Bulletin No. 222: Low‑Dose Aspirin Use for the Prevention of Preterm Preeclampsia.” 2020. https://www.acog.org
4. World Health Organization. “Calcium supplementation during pregnancy.” 2021. https://www.who.int

```